Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition
Open Access
- 5 January 2024
- journal article
- research article
- Published by Elsevier in Endocrine Practice
- Vol. 30 (4) , 311-318
Abstract
No abstract availableKeywords
Funding Information
- American Thyroid Association (THYROIDGRANT2021-0000000232)
This publication has 27 references indexed in Scilit:
- Current Update on Medullary Thyroid CarcinomaAmerican Journal of Roentgenology, 2013
- Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinomaDiseases of the Esophagus, 2013
- Localized Amyloid in ThyroidAdvances in Anatomic Pathology, 2013
- Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinomaBMC Cancer, 2012
- Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T MutationThyroid®, 2011
- Medullary Thyroid CarcinomaClinical Oncology, 2010
- Familial Medullary Thyroid Carcinoma Associated with Cutaneous Lichen AmyloidosisThyroid®, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Molecular Aspects and Natural Source of ProcalcitoninClinical Chemistry and Laboratory Medicine (CCLM), 1999
- Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.Journal of Experimental Medicine, 1976